0001493152-23-044430.txt : 20231211 0001493152-23-044430.hdr.sgml : 20231211 20231211171840 ACCESSION NUMBER: 0001493152-23-044430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231207 FILED AS OF DATE: 20231211 DATE AS OF CHANGE: 20231211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Coste Catherine CENTRAL INDEX KEY: 0001821432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37863 FILM NUMBER: 231478996 MAIL ADDRESS: STREET 1: 966 OCHO RIOS DR CITY: DANVILLE STATE: CA ZIP: 94526 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMERICA INC CENTRAL INDEX KEY: 0000073290 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 952645573 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 BUSINESS ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9493792875 MAIL ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19871130 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19830216 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC DATE OF NAME CHANGE: 19720508 4 1 ownership.xml X0508 4 2023-12-07 0 0000073290 BIOMERICA INC BMRA 0001821432 Coste Catherine 17571 VON KARMAN AVE IRVINE CA 92614 1 0 0 0 0 Common stock 43790 D Non-qualified stock option 1.67 2023-04-20 4 A 0 32000 A 2023-12-07 2033-04-20 Common Stock 32000 32000 D Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023. Not Applicable /s/ Catherine Coste 2023-12-11